HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: AJPH.2008.142703v1 98/9/1545    most recent Submit a response View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Goldman, J. Articles by Rothman, D. J. Search for Related Content PubMed Articles by Goldman, J. Articles by Rothman, D. J. Related Collections Diabetes Health Policy HIV/AIDS Public Health Practice

Janlori Goldman, JD, Sydney Kinnear, BA, Jeannie Chung, BA and David J. Rothman, PhD

Janlori Goldman is with the Department of Sociomedical Sciences, Mailman School of Public Health, Columbia University, New York, NY, and the Health Privacy Project, Center for Democracy and Technology, Washington, DC. Sydney Kinnear is with the Center on Medicine as a Profession (CMAP), College of Physicians and Surgeons, Co-lumbia University, New York, NY. Jeannie Chung is a first year law student at Brooklyn Law School, Brooklyn, NY. David J. Rothman is with the College of Physicians and Surgeons and the Institute on Medicine as a Profession, Columbia University, New York.

Correspondence: Requests for reprints should be sent to David J. Rothman, Institute on Medicine as a Profession, College of Physicians and Surgeons, Columbia University, 630 West 168th Street, P&S Box 11, New York, NY 10032 (e-mail: djr5@colubmia.edu).

	Because this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

We address the larger points about diabetes surveillance and written informed consent for HIV testing in our response to New York City Health Department Commissioner Thomas R. Frieden. More specifically, in response to Das-Douglas et al., we believe that written consent for HIV testing is not a barrier to routine testing. Rather, it is an essential safeguard ensuring that physicians will fully discuss the procedure, its consequences (in particular, possible discrimination), and alternatives (in particular, anonymous testing) with patients. Without this safeguard, there is no way to guarantee, in overwhelmed health care settings, that oral consent is obtained or that . . . [Full Text]